Van Hulzen Asset Management, LLC
Source: SEC Form 13F · as of Mar 2026Van Hulzen Asset Management, LLC holds 17 biotech & pharma companies tracked by BioSniper, totaling $64.5M in value as of Mar 2026 (SEC Form 13F).
Companies held
17
Total value held
$64.5M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 123,829 | $30.3M |
| ABBVAbbVie Inc. | 45,864 | $10.0M |
| MCKMcKesson Corporation | 4,434 | $3.8M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 9,845 | $2.7M |
| GMEDGlobus Medical Inc. | 30,869 | $2.7M |
| AMGNAMGEN INC | 6,025 | $2.1M |
| LLYELI LILLY & Co | 2,088 | $1.9M |
| ABTABBOTT LABORATORIES | 17,889 | $1.8M |
| MRKMerck & Co., Inc. | 14,051 | $1.7M |
| MMSIMerit Medical Systems Inc. | 23,099 | $1.6M |
| GILDGILEAD SCIENCES, INC. | 8,156 | $1.1M |
| PFEPFIZER INC | 39,543 | $1.1M |
| BMYBRISTOL MYERS SQUIBB CO | 17,594 | $1.1M |
| PMPhilip Morris International Inc | 5,442 | $900K |
| CORCencora Inc. | 2,828 | $888K |
| PBHPrestige Consumer Healthcare Inc. | 13,003 | $771K |
| XERSXeris Biopharma Holdings, Inc. | 19,382 | $112K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.